The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from GlobeNewswire (a Nasdaq OMX company)

Integra LifeSciences to Present at the Lazard Capital Markets Healthcare and Piper Jaffray Health Care Conferences in November

Monday, November 07, 2011

Integra LifeSciences to Present at the Lazard Capital Markets Healthcare and Piper Jaffray Health Care Conferences in November06:00 EST Monday, November 07, 2011PLAINSBORO, N.J., Nov. 7, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences this month: At 11:30 AM ET on Tuesday, November 15, 2011, Mr. Stuart Essig, Chief Executive Officer of Integra, will present at the Lazard Capital Markets Healthcare Conference in New York City. This presentation will not be webcast. At 9:30 AM ET on Wednesday, November 30, 2011, Mr. Jack Henneman, Chief Financial Officer of Integra, will present at the Piper Jaffray Healthcare Conference in New York City. This presentation will not be webcast. Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as of the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.CONTACT: Integra LifeSciences Holdings Corporation John B. Henneman, III Executive Vice President, Chief Financial Officer (609) 275-0500 jack.henneman@integralife.com Investor Relations: Angela Steinway (609) 936-2268 angela.steinway@integralife.com